Xilio Therapeutics, Inc. (XLO) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$35.04M | +39.8% |
| 2024 | -$58.24M | +23.8% |
| 2023 | -$76.40M | +13.4% |
| 2022 | -$88.22M | -16.4% |
| 2021 | -$75.80M | -37.3% |
| 2020 | -$55.22M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$35.04M | +39.8% |
| 2024 | -$58.24M | +23.8% |
| 2023 | -$76.40M | +13.4% |
| 2022 | -$88.22M | -16.4% |
| 2021 | -$75.80M | -37.3% |
| 2020 | -$55.22M | — |